Androgen receptor as potential therapeutic target in metastatic endometrial cancer

Abstract

A large proportion of metastatic endometrial cancer lesions express AR, which may be a potential target in these patients. Treatment targeting AR may be of particular benefit in patients with high AR levels compared to ERα levels.